Cargando…

Estimating patient health in prostate cancer treatment counseling

BACKGROUND: We assessed the concordance among urologists’ judgement of health quartiles for patients with localized prostate cancer, and compared the life expectancy (LE) and ensuing treatment recommendations when following National Comprehensive Cancer Network (NCCN) guidelines based on actuarial l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chesnut, Gregory T., Tin, Amy L., Fleshner, Katherine A., Benfante, Nicole E., Vickers, Andrew J., Eastham, James A., Sjoberg, Daniel D., Carlsson, Sigrid V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061891/ https://www.ncbi.nlm.nih.gov/pubmed/34732855 http://dx.doi.org/10.1038/s41391-021-00467-5

Ejemplares similares

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
por: Carlsson, Sigrid, et al.
Publicado: (2014)

Spotlight on prostate cancer: the latest evidence and current controversies
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Active surveillance should be considered for select men with Grade Group 2 prostate cancer
por: Pekala, Kelly R., et al.
Publicado: (2023)

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
por: Sivaraman, Arjun, et al.
Publicado: (2018)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

On Risk Estimation versus Risk Stratification in Early Prostate Cancer
por: Carlsson, Sigrid V., et al.
Publicado: (2016)

Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence
por: Stattin, Pär, et al.
Publicado: (2014)

Asian-American Race and Urinary Continence After Radical Prostatectomy
por: Hu, Jim C., et al.
Publicado: (2020)

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
por: Haese, Alexander, et al.
Publicado: (2020)

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
por: Vickers, Andrew J, et al.
Publicado: (2014)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
por: Heijnsdijk, Eveline A M, et al.
Publicado: (2020)

Pain as bad as you can imagine or extremely severe pain? A randomized controlled trial comparing two pain scale anchors
por: Tin, Amy L., et al.
Publicado: (2023)

Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer
por: Austria, Mia, et al.
Publicado: (2023)

Effects of surgeon variability on oncologic and functional outcomes in a population-based setting
por: Carlsson, Sigrid, et al.
Publicado: (2014)

Prostate cancer screening
por: Eastham, James
Publicado: (2017)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project
por: Assel, Melissa J., et al.
Publicado: (2017)

Who and when should we screen for prostate cancer? Interviews with key opinion leaders
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
por: Ulmert, David, et al.
Publicado: (2008)

Prostate cancer screening—when to start and how to screen?
por: Kohestani, Kimia, et al.
Publicado: (2018)

Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy
por: Mungovan, Sean F., et al.
Publicado: (2021)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

Updated counselling for the patient with prostate cancer
por: Bissada, Nabil K., et al.
Publicado: (2011)

Empiric Recurrence Risk Estimates for Chronic Tic Disorders: Implications for Genetic Counseling
por: Heiman, Gary A., et al.
Publicado: (2020)

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire
por: Gewanter, Richard M., et al.
Publicado: (2023)

The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models
por: Assel, Melissa, et al.
Publicado: (2017)

The impact of population heterogeneity on risk estimation in genetic counseling
por: Liu, Wenlei, et al.
Publicado: (2004)

Germline testing and genetic counselling in prostate cancer
por: Russo, Jessica, et al.
Publicado: (2022)

Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
por: Fredsøe, Jacob, et al.
Publicado: (2022)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Germline retinoblastoma: estimating risk and counselling the family
por: Rosser, Elisabeth, et al.
Publicado: (2018)

Validation study of a web-based assessment of functional recovery after radical prostatectomy
por: Vickers, Andrew J, et al.
Publicado: (2010)

Incorporating medical interventions into carrier probability estimation for genetic counseling
por: Katki, Hormuzd A
Publicado: (2007)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
por: Nyberg, Martin, et al.
Publicado: (2020)

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
por: Vickers, Andrew J, et al.
Publicado: (2013)

Oral contraceptive use is associated with prostate cancer: an ecological study
por: Margel, David, et al.
Publicado: (2011)

Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States
por: Merrill, Ray M., et al.
Publicado: (2022)

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy
por: Vickers, Andrew J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_19tapk53hiutt5mi76vqtrgr7a